Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE004 (DEU) (Dr. Tanaka)
· consented 2023-02-05
Adverse events
3
Serious AEs
1
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-05-19 (study day 92); relationship: not assessed
severe
serious
assessed
2026-08-18
Grade 4 Anaemia — outcome: UNKNOWN; onset 2024-06-15 (study day 485); relationship: Y; serious criteria: life-threatening
mild
assessed
2026-08-18
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2024-07-05 (study day 505); relationship: not assessed
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.